TrialThe oncologist2023

Three-Week Versus 4-Week Schedule of nab-Paclitaxel in Patients With Metastatic Breast Cancer: A Randomized Phase II Study.

Yaxin Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.